Skim the pharma news outlet of your choice, and it’s clear…
Category: Obesity
Home /
Millions of people take glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide…
In most mammals, the act of running is fueled primarily by…
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom),…
Eli Lilly has launched a new way for patients to access…
Medicare may soon face steeply increased prescription drug costs as it…
Advocates of fasting point to the potential health and longevity benefits,…
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in…
The Danish pharmaceutical company Novo Nordisk has announced promising early results…
NodThera, a biotech company based in Cambridge, England, is developing a…
As GLP-1 receptor agonist injections continue to gain acceptance as effective…
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in…
Research using data from a large U.S. health survey has disrupted…
Lurking among the vast genetic holdings of the UK Biobank data,…
Gene therapy offers hope for treating a wide range of inherited…
Recent headlines have been abuzz with the groundbreaking weight loss results…
Clinical trial data has demonstrated that the anti-obesity drug semaglutide, marketed…
For years, obesity and weight gain have been blamed on the…
Danish pharmaceutical giant Novo Nordisk changed the game last year, presenting…
The World Health Organization reports that around 13 percent of the world’s population…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
Webinars
Pharma Strikes Back at Compounding Pharmacies
March 12, 2025
Skim the pharma news outlet of your choice, and it’s clear that compounding pharmacies have been making headlines. These pharmacies typically provide one of three
Eyeing Potential Risks: Investigating Vision Changes Linked to GLP-1 Drugs
March 3, 2025
Millions of people take glucagon-like peptide-1 (GLP-1) receptor agonists like semaglutide and tirzepatide to manage diabetes and obesity. These drugs have transformed weight loss and
Tiny Treadmills: Vampire Bats on the Go
January 29, 2025
In most mammals, the act of running is fueled primarily by the oxidization of carbohydrates and lipids, which are stored in the body as fuel.
Rezdiffra Gains Approval, Marks a New Chapter in Treating NASH (MASH) with Liver Scarring
November 4, 2024
The US Food and Drug Administration (FDA) has approved Rezdiffra™ (resmetirom), the first medication for treating patients with nonalcoholic steatohepatitis (NASH) with moderate to advanced
Weight Loss Drug Prescriptions Become More Accessible With Single-Dose Option
October 21, 2024
Eli Lilly has launched a new way for patients to access its popular weight loss drug, Zepbound® (tirzepatide). The company now offers single-dose vials at
Sizing Up Potential Medicare Costs of Covering Weight Loss Drugs for Heart Health
October 14, 2024
Medicare may soon face steeply increased prescription drug costs as it considers covering the popular weight loss drug, Wegovy® (semaglutide). Known for its ability to
Going Cold Turkey — How a Week-Long Fast Affects Your Health
July 31, 2024
Advocates of fasting point to the potential health and longevity benefits, often citing results from animal studies. However, the impact of prolonged calorie restriction on
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
June 3, 2024
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk of
Novo Nordisk Offers a New Contender in Weight Management — in Pill Form
May 20, 2024
The Danish pharmaceutical company Novo Nordisk has announced promising early results for amycretin, a novel oral weight loss medication. This new drug appears to outperform
New Class of Weight Loss Drugs Shows Promise in Treating Heart Disease
April 15, 2024
NodThera, a biotech company based in Cambridge, England, is developing a new class of medicines that inhibit the NOD-, LRR- and pyrin domain-containing protein 3
Vivani Shifts to Weight Management with an Exenatide Implant
April 1, 2024
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani Medical
The Link Between Obesity Drugs and Brain Health
March 6, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in medical innovation. The drugs semaglutide and tirzepatide, known under brand names like Ozempic, Wegovy,
Research Challenges Conventional Wisdom on Obesity and Mortality
February 26, 2024
Research using data from a large U.S. health survey has disrupted conventional thinking about body mass index (BMI) and its role in predicting all-cause mortality.
Could Newly Identified Genetic Variant Hold the Key to Metabolic Health?
February 14, 2024
Lurking among the vast genetic holdings of the UK Biobank data, researchers uncovered a potential gem — a gene variant linked to cardiometabolic health. Conditions
Gene Therapy for Muscular Dystrophy and Obesity
December 13, 2023
Gene therapy offers hope for treating a wide range of inherited and acquired diseases and conditions, ranging from muscular dystrophy to obesity. Gene therapy for
Examining the Expanding Landscape of Weight Loss Injectables
September 25, 2023
Recent headlines have been abuzz with the groundbreaking weight loss results achieved with the injectable drug semaglutide, demonstrating the potential for people with obesity to
Changing the Game for Obesity Treatment and Cardiovascular Care
September 11, 2023
Clinical trial data has demonstrated that the anti-obesity drug semaglutide, marketed for obesity and diabetes, could offer substantial protection against heart disease. The results could
Do Obesogens Cause Obesity?
April 12, 2023
For years, obesity and weight gain have been blamed on the “calorie concept”: the idea that obesity is caused by taking in more calories (through
New Obesity Drug Shows Great Promise in Phase III Trials
June 22, 2022
Danish pharmaceutical giant Novo Nordisk changed the game last year, presenting data that suggested one of the company’s diabetes drugs was also highly effective at
14 Obesity Genes Discovered
December 15, 2021
The World Health Organization reports that around 13 percent of the world’s population is classified as “obese.” Today, medical experts know that obesity is much more than
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
QPS India has achieved another significant milestone by successfully completing a scheduled inspection by the UK Medicines and Healthcare products Regulatory Agency (MHRA) from…
